Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M M Breteler

Showing results (41-50 of 112) with videos related to

Pageof 12
Sort By:
Neurology|December 22, 1999
Head trauma and risk of dementia and Alzheimer's disease: The Rotterdam StudyK M Mehta, A Ott, S Kalmijn, et al.
Neurology|February 20, 1999
Cerebral vasomotor reactivity and cerebral white matter lesions in the elderlyS L Bakker, F E de Leeuw, J C de Groot, et al.
Neurology|May 1, 1997
A population perspective on diagnostic criteria for Parkinson's diseaseM C de Rijk, W A Rocca, D W Anderson, et al.
Diabetes Care|May 1, 1997
Insulin and cognitive function in an elderly population. The Rotterdam StudyR P Stolk, M M Breteler, A Ott, et al.
Archives of Neurology|July 25, 1998
Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study: the Rotterdam StudyA J Slooter, M Cruts, S Kalmijn, et al.
European Journal of Epidemiology|July 15, 1998
A study of familial aggregation of depression, dementia and Parkinson's diseaseS Fahim, C M van Duijn, F M Baker, et al.
Journal of Cardiovascular Risk|March 2, 2002
Underestimation of the importance of homocysteine as a risk factor for cardiovascular disease in epidemiological studiesR Clarke, S Lewington, A Donald, et al.
Annals of Neurology|February 9, 2000
Cerebral white matter lesions and cognitive function: the Rotterdam Scan StudyJ C de Groot, F E de Leeuw, M Oudkerk, et al.
Neurology|June 15, 2000
Frequency of stroke in Europe: A collaborative study of population-based cohorts. ILSA Working Group and the Neurologic Diseases in the Elderly Research Group. Italian Longitudinal Study on AgingA Di Carlo, L J Launer, M M Breteler, et al.
Pharmacy World & Science : PWS|October 16, 2001
Evaluation of antiparkinsonian drugs in pharmacy records as a marker for Parkinson's diseaseD A van de Vijver, B H Stricker, M M Breteler, et al.
Pageof 12

Showing results (41-50 of 112) with videos related to

Sort By:
Pageof 12
Neurology|December 22, 1999
Head trauma and risk of dementia and Alzheimer's disease: The Rotterdam StudyK M Mehta, A Ott, S Kalmijn, et al.
Neurology|February 20, 1999
Cerebral vasomotor reactivity and cerebral white matter lesions in the elderlyS L Bakker, F E de Leeuw, J C de Groot, et al.
Neurology|May 1, 1997
A population perspective on diagnostic criteria for Parkinson's diseaseM C de Rijk, W A Rocca, D W Anderson, et al.
Diabetes Care|May 1, 1997
Insulin and cognitive function in an elderly population. The Rotterdam StudyR P Stolk, M M Breteler, A Ott, et al.
Archives of Neurology|July 25, 1998
Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study: the Rotterdam StudyA J Slooter, M Cruts, S Kalmijn, et al.
European Journal of Epidemiology|July 15, 1998
A study of familial aggregation of depression, dementia and Parkinson's diseaseS Fahim, C M van Duijn, F M Baker, et al.
Journal of Cardiovascular Risk|March 2, 2002
Underestimation of the importance of homocysteine as a risk factor for cardiovascular disease in epidemiological studiesR Clarke, S Lewington, A Donald, et al.
Annals of Neurology|February 9, 2000
Cerebral white matter lesions and cognitive function: the Rotterdam Scan StudyJ C de Groot, F E de Leeuw, M Oudkerk, et al.
Neurology|June 15, 2000
Frequency of stroke in Europe: A collaborative study of population-based cohorts. ILSA Working Group and the Neurologic Diseases in the Elderly Research Group. Italian Longitudinal Study on AgingA Di Carlo, L J Launer, M M Breteler, et al.
Pharmacy World & Science : PWS|October 16, 2001
Evaluation of antiparkinsonian drugs in pharmacy records as a marker for Parkinson's diseaseD A van de Vijver, B H Stricker, M M Breteler, et al.
Pageof 12